Concord Wealth Partners’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-464
Closed -$11K 1270
2022
Q1
$11K Buy
464
+88
+23% +$1.72K ﹤0.01% 755
2021
Q4
$7K Buy
376
+128
+52% +$2.45K ﹤0.01% 863
2021
Q3
$5K Buy
248
+179
+259% +$3.32K ﹤0.01% 577
2021
Q2
$1K Buy
+69
New +$1.61K ﹤0.01% 961

Other funds holding EXEL

Concord Wealth Partners's EXEL Position: Q2 2022 in Review

Concord Wealth Partners sold out of Exelixis (EXEL) in Q2 2022, closing a stake of 464 shares — an estimated $11K sold.

Concord Wealth Partners first reported a position in EXEL in Q2 2021 and held it in 4 quarters. The position peaked at $11K in Q1 2022. 373 funds tracked by Wall St. Rank hold EXEL as of Q2 2022.

  • Concord Wealth Partners reported no remaining Exelixis position as of Q2 2022 after selling out during the quarter.
  • Concord Wealth Partners sold 464 Exelixis shares in Q2 2022, an estimated $11K.
  • Concord Wealth Partners first reported a position in Exelixis in Q2 2021 and held it in 4 quarters.
  • Concord Wealth Partners's Exelixis position peaked at $11K in Q1 2022.
  • 373 funds tracked by Wall St. Rank held Exelixis as of Q2 2022.

Based on Concord Wealth Partners's 13F filing for Q2 2022, filed 4 Aug 2022.